Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.
about
Liposomal Formulations in Clinical Use: An Updated Review.Nanoyeast and Other Cell Envelope Compositions for Protein Studies and Biosensor Applications.On-chip density-based purification of liposomes.Delivering therapeutics in peripheral artery disease: challenges and future perspectives.Engineering liposomal nanoparticles for targeted gene therapy.Bioengineered liposome-scaffold composites as therapeutic delivery systems.Zeta potential: a case study of cationic, anionic, and neutral liposomes.Nanoparticle size and production efficiency are affected by the presence of fatty acids during albumin nanoparticle fabrication.Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review.Effects of surface charge of low molecular weight heparin-modified cationic liposomes on drug efficacy and toxicity.Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma.Idebenone: Novel Strategies to Improve Its Systemic and Local Efficacy.Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage.Recent Progress in Micro/Nanoreactors toward the Creation of Artificial Organelles.General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.The development of ruthenium(ii) polypyridyl complexes and conjugates for in vitro cellular and in vivo applications.Macrophage-Targeted Therapeutics for Metabolic Disease.Liposome Entrapment of Bacteriophages Improves Wound Healing in a Diabetic Mouse MRSA Infection.SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study.Nano based drug delivery systems: recent developments and future prospectsA novel microfluidic liposomal formulation for the delivery of the SN-38 camptothecin: characterization and in vitro assessment of its cytotoxic effect on two tumor cell lines
P2860
Q33850427-62EA600B-CD92-4A81-9514-EFCB4A5DC822Q36168796-4DBD02B7-4F95-47E4-AE9A-2F2F4B689E76Q38772043-C2CC13C0-8973-4CD4-A370-1A75AACC5964Q38842808-318FC26C-9787-4F91-9701-45193F069BFFQ39306702-C720790A-554F-417E-A8E0-8F6AC28EEC14Q39321867-58A588A2-C676-467F-8E37-477019CFA180Q46327978-7041D573-EB4C-463A-87E5-87C87707FC66Q47172898-A418A0E7-32E0-4D3F-99E9-2DD43A5809DCQ47190264-68D6E1A7-66FA-4B43-85A0-0A1686B4312BQ47229769-BB887D30-2F77-4204-BDFF-BA1CB35CDC9AQ48012324-BF8D424E-0108-44B3-BDFC-940A056E6AE5Q48104567-12BFA385-8C5F-48B9-BFC4-4252194D6514Q48166311-99BECC50-0BB2-4E56-8564-28A633F8E97CQ48177366-4A57CA49-F95F-45BF-9232-A05DF69EE5D6Q48257489-9A75BA68-E973-416F-B828-9DA6BD20CA3EQ49611544-B15A96AD-FB6E-4F86-9A61-BEEEC496F47DQ53697469-5FC89E87-8D85-46CC-8F9F-E6A2DD4B01E3Q54950902-3EEF17E8-7987-4876-89AF-C54703002D4FQ55379526-5459BFB4-0AB5-43F1-A6ED-1255A77FB743Q57154808-4B2ED256-F4FF-45DA-BB0D-8BB387AEC581Q58750910-C41B8C3C-C94C-4D52-AFE6-826D41FA642A
P2860
Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pharmaceutical liposomal drug ...... k at the regulatory landscape.
@en
type
label
Pharmaceutical liposomal drug ...... k at the regulatory landscape.
@en
prefLabel
Pharmaceutical liposomal drug ...... k at the regulatory landscape.
@en
P2860
P1433
P1476
Pharmaceutical liposomal drug ...... k at the regulatory landscape.
@en
P2093
Claudia Zylberberg
P2860
P304
P356
10.1080/10717544.2016.1177136
P407
P577
2016-05-05T00:00:00Z